SUBSEQUENT EVENTS (Details) - Subsequent Event [Member] $ / shares in Units, $ in Millions |
Mar. 08, 2021
USD ($)
$ / shares
shares
|
---|---|
PIPE Investment [Member] | |
SUBSEQUENT EVENTS | |
Stock issued, value | $ 25.0 |
Stock issued (in shares) | shares | 25,000 |
Share price (in dollars per share) | $ / shares | $ 1,000 |
Senior Secured Credit Facility 2021 [Member] | |
SUBSEQUENT EVENTS | |
Maximum borrowing capacity | $ 340.0 |
Senior Secured Credit Facility 2021 [Member] | Term Loan [Member] | |
SUBSEQUENT EVENTS | |
Maximum borrowing capacity | 300.0 |
Senior Secured Credit Facility 2021 [Member] | Revolver [Member] | |
SUBSEQUENT EVENTS | |
Maximum borrowing capacity | 40.0 |
Novitium Pharma [Member] | |
SUBSEQUENT EVENTS | |
Cash outflow in merger | $ 89.5 |
Equity issued in merger (in shares) | shares | 2,466,667 |
Contingent consideration | $ 46.5 |
Equity issued in merger, value | $ 74.0 |
X | ||||||||||
- Definition Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|